Dacihal 0.5mg Injection is FDA-approved for the treatment of the following cancers:

• Wilms' tumour (kidney cancer in children)
• Rhabdomyosarcoma (soft tissue cancer)
• Ewing’s sarcoma (bone cancer)
• Gestational trophoblastic neoplasia (cancer linked to pregnancy)
• Testicular cancer (when combined with other chemotherapy drugs)
• Certain types of solid tumours in children

Dactinomycin works by interfering with the DNA of cancer cells. It binds to their genetic material and prevents them from multiplying. When cancer cells can’t grow or divide, they eventually die. This helps to shrink tumours and slow down the spread of cancer. Since the drug targets rapidly dividing cells, it can also affect some healthy cells, which is why side effects may occur. However, its action makes it highly effective in stopping the progression of certain fast-growing cancers when used as prescribed by a cancer specialist.

Dacihal 0.5mg Injection should not be taken alongside certain medications or in specific health conditions due to the risk of serious side effects. Always inform your doctor about all the medications you take, including prescription drugs, over-the-counter products, and herbal supplements.

• Combining with live vaccines (e.g., MMR, BCG) can increase the risk of serious infections because Dactinomycin suppresses the immune system.
• When used with radiation therapy, there’s an increased risk of skin and tissue damage.
• Avoid using with other bone marrow suppressants like doxorubicin, as it may lead to dangerously low blood counts.
• Drugs that affect the liver, such as phenytoin or methotrexate, may increase toxicity due to altered metabolism.
• Antibiotics like trimethoprim-sulfamethoxazole can worsen blood-related side effects.

These interactions may not be exhaustive. Therefore, any new symptoms or unusual reactions should be immediately reported to your healthcare provider. Use of this medicine requires regular blood tests and clinical monitoring to avoid complications.

• Store in a refrigerator at 2°C – 8°C.
• Do not freeze.
• Inform your doctor if you miss a dose. Do not try to take a missed injection on your own.
• This medicine should only be handled by trained medical professionals in a clinical setting.

Dacihal 0.5mg Injection is given as an intravenous (IV) injection under the supervision of a trained oncologist or nurse. The dosage and schedule depend on the type of cancer being treated, the patient’s weight, and overall health. It is not taken orally and should never be self-administered. There are no food restrictions linked directly to this medicine, but patients should follow any dietary advice given by their doctor during treatment.

Dacihal 0.5mg Injection causes some side effects like all medications, although not everyone will experience them. 

Serious:

• Muscle pain or weakness
• Signs of an allergic reaction (rash, itching, swelling, severe dizziness, difficulty breathing)
• Eosinophilic pneumonia symptoms (cough, fever, difficulty breathing)

Common:

• Nausea
• Headache
• Diarrhea
• Vomiting

Dacihal 0.5mg Injection is a powerful chemotherapy drug and should only be taken under close medical supervision. During treatment, it is important to maintain good hygiene and avoid crowded places to reduce infection risk due to a weakened immune system. Patients are advised to follow up regularly for blood tests and liver function monitoring. Report any signs of fever, unusual tiredness, or bleeding to your doctor immediately. Avoid self-medicating or taking any other drug without your oncologist's approval during the course of therapy.

1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf
2. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/dactinomycin
3. https://go.drugbank.com/drugs/DB00970
4. https://www.cancer.gov/about-cancer/treatment/drugs/dactinomycin